1. Home
  2. BDX vs A Comparison

BDX vs A Comparison

Compare BDX & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Becton Dickinson and Company

BDX

Becton Dickinson and Company

N/A

Current Price

$215.59

Market Cap

54.6B

Sector

Health Care

ML Signal

N/A

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

N/A

Current Price

$173.69

Market Cap

49.9B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BDX
A
Founded
1897
1999
Country
United States
United States
Employees
N/A
18200
Industry
Medical/Dental Instruments
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
54.6B
49.9B
IPO Year
1999
1999

Fundamental Metrics

Financial Performance
Metric
BDX
A
Price
$215.59
$173.69
Analyst Decision
Buy
Buy
Analyst Count
16
22
Target Price
★ $226.14
$182.05
AVG Volume (30 Days)
★ 1.8M
1.6M
Earning Date
11-05-2026
11-23-2026
Dividend Yield
★ 1.98%
0.58%
EPS Growth
N/A
★ 3.16
EPS
1.59
★ 3.55
Revenue
★ $21,840,000,000.00
$4,472,000,000.00
Revenue This Year
$1.74
$7.94
Revenue Next Year
$4.24
$6.42
P/E Ratio
$134.67
★ $50.15
Revenue Growth
★ 8.24
6.43
52 Week Low
$140.11
$108.35
52 Week High
$216.74
$182.99

Technical Indicators

Market Signals
Indicator
BDX
A
Relative Strength Index (RSI) 73.59 50.56
Support Level $175.60 $170.33
Resistance Level N/A $177.05
Average True Range (ATR) 4.59 5.12
MACD 1.13 -0.63
Stochastic Oscillator 93.02 24.75

Price Performance

Historical Comparison
BDX
A

About BDX Becton Dickinson and Company

Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Share on Social Networks: